IMPLEMENTATION GUIDE AMERICAN SOCIETY FOR AUTOMATION IN PHARMACY STANDARD FOR PRESCRIPTION DRUG MONITORING PROGRAMS

Welcome to the Brand page for “IMPLEMENTATION GUIDE AMERICAN SOCIETY FOR AUTOMATION IN PHARMACY STANDARD FOR PRESCRIPTION DRUG MONITORING PROGRAMS”, which is offered here for He american society for automation in pharmacy developed and publishes the implementation guide for the standard that every state prescription drug monitory program in the country requires that pharmacies use to report the controlled substances dispensed as well as other drugs of interest to these programs. as such the american society for automation in pharmacy, through its reporting standard, is helping reduce the abuse and diversion of opioids and other addictive drugs. the standard was developed in 1995 and enhanced over the years to include new data elements that would increase the completeness of the information reported to prescription drug monitoring programs. the standard also includes a standardized way for the monitoring programs to transmit errors in the files submitted that have to be corrected and resubmitted as wells as a way for pharmacies to report that no controlled substances were dispensed during the reporting time period;.

Its status is currently believed to be active. Its class is unavailable. “IMPLEMENTATION GUIDE AMERICAN SOCIETY FOR AUTOMATION IN PHARMACY STANDARD FOR PRESCRIPTION DRUG MONITORING PROGRAMS” is believed to be currently owned by “American Society for Automation in Pharmacy”.

Owner:
AMERICAN SOCIETY FOR AUTOMATION IN PHARMACY
Owner Details
Description:
He American Society for Automation in Pharmacy developed and publishes the implementation guide for the standard that every state Prescription Drug Monitory Program in the country requires that pharmacies use to report the controlled substances dispensed as well as other drugs of interest to these programs. As such the American Society for Automation in Pharmacy, through its reporting standard, is helping reduce the abuse and diversion of opioids and other addictive drugs. The standard was developed in 1995 and enhanced over the years to include new data elements that would increase the completeness of the information reported to Prescription Drug Monitoring Programs. The standard also includes a standardized way for the monitoring programs to transmit errors in the files submitted that have to be corrected and resubmitted as wells as a way for pharmacies to report that no controlled substances were dispensed during the reporting time period;
Categories: PHARMACY